(Q35143886)

6 August 2017

1 reference

title

Vancomycin resistance: occurrence, mechanisms and strategies to combat it. (English)

1 reference

6 August 2017

0 references

2

Gabriela Chiosis

0 references

Ivo G Boneca

object named as

Ivo G Boneca

series ordinal

1

0 references

language of work or name

English

0 references

publication date

1 June 2003

1 reference

Expert Opinion on Therapeutic Targets

6 August 2017

1 reference

6 August 2017

7

1 reference

6 August 2017

311-328

1 reference

6 August 2017

3

1 reference

Vancomycin-resistant enterococci

6 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Structure, biochemistry and mechanism of action of glycopeptide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Vancomycin resistance: decoding the molecular logic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

In vivo characterization of the type A and B vancomycin-resistant enterococci (VRE) VanRS two-component systems in Escherichia coli: a nonpathogenic model for studying the VRE signal transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Structural relationship between the vancomycin resistance protein VanH and 2-hydroxycarboxylic acid dehydrogenases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Phosphinate analogs of D-, D-dipeptides: slow-binding inhibition and proteolysis protection of VanX, a D-, D-dipeptidase required for vancomycin resistance in Enterococcus faecium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Glycopeptide resistance mediated by enterococcal transposon Tn1546 requires production of VanX for hydrolysis of D-alanyl-D-alanine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Requirement of the VanY and VanX D,D-peptidases for glycopeptide resistance in enterococci.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Genetic characterization of vanG, a novel vancomycin resistance locus of Enterococcus faecalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Intrinsically vancomycin-resistant gram-positive organisms: clinical relevance and implications for infection control

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Structural modifications of glycopeptide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Fluorobalhimycin--a new chapter in glycopeptide antibiotic research

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-Ala-D-Ala.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Direct interaction of a vancomycin derivative with bacterial enzymes involved in cell wall biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Selective cleavage of D-Ala-D-Lac by small molecules: re-sensitizing resistant bacteria to vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Antibody-catalyzed cleavage of the D-Ala-D-Lac depsipeptide: an immunological approach to the problem of vancomycin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Sites of interaction of streptogramin A and B antibiotics in the peptidyl transferase loop of 23 S rRNA and the synergism of their inhibitory mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

An Enterococcus faecalis ABC homologue (Lsa) is required for the resistance of this species to clindamycin and quinupristin-dalfopristin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Mutation in 23S rRNA responsible for resistance to 16-membered macrolides and streptogramins in Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Resistance to quinupristin-dalfopristin due to mutation of L22 ribosomal protein in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Vgb from Staphylococcus aureus inactivates streptogramin B antibiotics by an elimination mechanism not hydrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Tn5406, a new staphylococcal transposon conferring resistance to streptogramin a and related compounds including dalfopristin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Characterization of a variant of vga(A) conferring resistance to streptogramin A and related compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Characterisation and molecular cloning of the novel macrolide-streptogramin B resistance determinant from Staphylococcus epidermidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Macrolide resistance genes in Enterococcus spp

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Disruption of an Enterococcus faecium species-specific gene, a homologue of acquired macrolide resistance genes of staphylococci, is associated with an increase in macrolide susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

The newly described msrC gene is not equally distributed among all isolates of Enterococcus faecium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Interactions of quinupristin-dalfopristin with eight other antibiotics as measured by time-kill studies with 10 strains of Staphylococcus aureus for which quinupristin-dalfopristin alone was not bactericidal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Quinupristin-dalfopristin combined with beta-lactams for treatment of experimental endocarditis due to Staphylococcus aureus constitutively resistant to macrolide-lincosamide-streptogramin B antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

In-vitro activity and killing effect of quinupristin/dalfopristin (RP59500) on nosocomial Staphylococcus aureus and interactions with rifampicin and ciprofloxacin against methicillin-resistant isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Combination of quinupristin-dalfopristin (Synercid) and rifampin is highly synergistic in experimental Staphylococcus aureus joint prosthesis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Efficacies of quinupristin-dalfopristin combined with vancomycin in vitro and in experimental endocarditis due to methicillin-resistant Staphylococcus aureus in relation to cross-resistance to macrolides, lincosamides, and streptogramin B- type anti

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Antimicrobial activity of quinupristin-dalfopristin combined with other antibiotics against vancomycin-resistant enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

In vitro activities of quinupristin-dalfopristin and cefepime, alone and in combination with various antimicrobials, against multidrug-resistant staphylococci and enterococci in an in vitro pharmacodynamic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Combination of quinupristin-dalfopristin and gentamicin against methicillin-resistant Staphylococcus aureus: experimental rabbit endocarditis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Treatment of endocarditis due to vancomycin-resistant Enterococcus faecium with quinupristin/dalfopristin, doxycycline, and rifampin: a synergistic drug combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Linezolid resistance in a clinical isolate of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

A novel site of antibiotic action in the ribosome: interaction of evernimicin with the large ribosomal subunit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Comparative in-vitro activity of SCH 27899, a novel everninomicin, and vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Effects of mutations in ribosomal protein L16 on susceptibility and accumulation of evernimicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Presence of variations in ribosomal protein L16 corresponding to susceptibility of enterococci to oligosaccharides (Avilamycin and evernimicin).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Evernimicin (SCH27899) inhibits a novel ribosome target site: analysis of 23S ribosomal DNA mutants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Mutations in ribosomal protein L16 conferring reduced susceptibility to evernimicin (SCH27899): implications for mechanism of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

EmtA, a rRNA methyltransferase conferring high-level evernimicin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Inhibition of membrane potential-dependent amino acid transport by daptomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Resistance studies with daptomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Effect of protein binding of daptomycin on MIC and antibacterial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Development of daptomycin for gram-positive infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

A critical review of the fluoroquinolones: focus on respiratory infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

The ketolides: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Antibacterial agents based on the cyclic D,L-alpha-peptide architecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Artificial transmembrane ion channels from self-assembling peptide nanotubes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

The bacterial cell wall as a source of antibacterial targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

FemABX family members are novel nonribosomal peptidyltransferases and important pathogen-specific drug targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

The targeting of factors necessary for expression of methicillin resistance in staphylococci.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Cell wall monoglycine cross-bridges and methicillin hypersusceptibility in a femAB null mutant of methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

The essential Staphylococcus aureus gene fmhB is involved in the first step of peptidoglycan pentaglycine interpeptide formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

The murMN operon: a functional link between antibiotic resistance and antibiotic tolerance in Streptococcuspneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Inhibition of the expression of penicillin resistance in Streptococcus pneumoniae by inactivation of cell wall muropeptide branching genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

A bacteriolytic agent that detects and kills Bacillus anthracis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

The lysis protein E of phi X174 is a specific inhibitor of the MraY-catalyzed step in peptidoglycan synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Genetic evidence that the bacteriophage phi X174 lysis protein inhibits cell wall synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

Antimicrobial use in animal feed--time to stop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.3.311

A-16686, a new antibiotic from Actinoplanes. I. Fermentation, isolation and preliminary physico-chemical characteristics

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.37.309

Identifiers

DOI

10.1517/14728222.7.3.311

1 reference

6 August 2017

1 reference

PubMed ID

12783569